Agonist Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 1.50 Cr
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 2.70 Cr
- Revenue Growth 49.81%
- Profit Growth -16.13%
- Ebitda 60.08%
- Net Worth 21.53%
- Total Assets 16.82%
About Agonist Pharmaceuticals
Agonist Pharmaceuticals Private Limited (APPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 06 July 2017 (Seven years and eight months 23 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr.
The company has closed loans amounting to ₹2.70 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rohit Madariya, Dhaval Kamani, Bharatbhai Kamani, and One other member serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999GJ2017PTC098175
- Company No.
098175
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jul 2017
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Pharma
Who are the key members and board of directors at Agonist Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohit Madariya  | Director | 06-Jul-2017 | Current |
| Dhaval Kamani | Director | 06-Jul-2017 | Current |
| Bharatbhai Kamani | Director | 06-Jul-2017 | Current |
| Jay Pragda | Director | 06-Jul-2017 | Current |
Financial Performance of Agonist Pharmaceuticals.
Agonist Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 49.81% increase. The company also saw a substantial fall in profitability, with a 16.13% decrease in profit. The company's net worth Soared by an impressive increase of 21.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Agonist Pharmaceuticals?
Unlock access to Agonist Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Open Charges
₹0
Satisfied Charges
₹2.70 Cr
Charges Breakdown by Lending Institutions
- The Kalupur Commercial Co-Operative Bank Limited : 2.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jul 2018 | The Kalupur Commercial Co-Operative Bank Limited | ₹2.70 Cr | Satisfied |
How Many Employees Work at Agonist Pharmaceuticals?
Agonist Pharmaceuticals has a workforce of 9 employees as of Feb 18, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agonist Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agonist Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Agonist Pharmaceuticals
Recent activity within the organization
- Charges
A charge registered on 24 Jul 2018 via Charge ID 100193587 with The Kalupur Commercial Co-Operative Bank Limited was fully satisfied on 24 Dec 2024.
- Annual General Meeting
Agonist Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
- Balance Sheet
Agonist Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Ahmedabad.
- Charges
A charge with The Kalupur Commercial Co-Operative Bank Limited of Rs. 2.70 Cr registered on 24 Jul 2018 with Charge ID 100193587 was modified on 10 Nov 2020.
- Charges
A charge with The Kalupur Commercial Co-Operative Bank Limited amounted to Rs. 2.70 Cr with Charge ID 100193587 was registered on 24 Jul 2018.
- Director Appointment
Rohit Vallabhbhai Madariya was appointed as a Director was appointed as a Director on 06 Jul 2017 & has been associated with this company since 7 years 8 months .
Frequently asked questions
What is the Incorporation or founding date of Agonist Pharmaceuticals Private Limited?
Agonist Pharmaceuticals Private Limited was incorporated on 06 Jul 2017.
What is authorized share capital and paid-up capital of Agonist Pharmaceuticals Private Limited?
The authorized share capital of Agonist Pharmaceuticals Private Limited is ₹ 1.50 Cr and paid-up capital is ₹ 1.50 Cr.
Who are the current board members & directors of Agonist Pharmaceuticals Private Limited?
Currently 4 directors are associated with Agonist Pharmaceuticals Private Limited.
- Rohit Vallabhbhai Madariya
- Dhaval Bharatbhai Kamani
- Bharatbhai Ramjibhai Kamani
- Jay Pragda
What is the registered address of Agonist Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Agonist Pharmaceuticals Private Limited is Plot No. 20 Somnath Ind. Park Near Kerala Gidc Village: Kerala Taluka :Bavla, India, Ahmedabad, Gujarat, 382220.
What is the corporate identification number (CIN) and company number of Agonist Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Agonist Pharmaceuticals Private Limited is U74999GJ2017PTC098175 and the company number is 098175 as per Ministry of Corporate Affairs (MCA).
What is the official website of Agonist Pharmaceuticals Private Limited?
The Official website of Agonist Pharmaceuticals Private Limited is https://www.agonistpharma.com
What has been the recent revenue trend for Agonist Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Agonist Pharmaceuticals Private Limited has risen by 49.81%.
How many employees does Agonist Pharmaceuticals Private Limited currently have?
As Per 2022 financial reports, 9 employees are currently employed by Agonist Pharmaceuticals Private Limited.
What change has been observed in the net worth of Agonist Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Agonist Pharmaceuticals Private Limited has experienced an upsurge of 21.53%.
When was the last Balance Sheet of Agonist Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Agonist Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2022.
People also Viewed
RD
Rohit DongaDirector